AU508625B2 - Stable solutions hydrogenated ergopeptide alkaloids - Google Patents

Stable solutions hydrogenated ergopeptide alkaloids

Info

Publication number
AU508625B2
AU508625B2 AU14422/76A AU1442276A AU508625B2 AU 508625 B2 AU508625 B2 AU 508625B2 AU 14422/76 A AU14422/76 A AU 14422/76A AU 1442276 A AU1442276 A AU 1442276A AU 508625 B2 AU508625 B2 AU 508625B2
Authority
AU
Australia
Prior art keywords
stable solutions
hydrogenated
alkaloids
ergopeptide alkaloids
hydrogenated ergopeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU14422/76A
Other languages
English (en)
Other versions
AU1442276A (en
Inventor
L. Hartmann V. Patt L Ehrhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU1442276A publication Critical patent/AU1442276A/en
Application granted granted Critical
Publication of AU508625B2 publication Critical patent/AU508625B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
AU14422/76A 1975-05-31 1976-05-28 Stable solutions hydrogenated ergopeptide alkaloids Expired AU508625B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2524184 1975-05-31
DEDE2524184 1975-05-31

Publications (2)

Publication Number Publication Date
AU1442276A AU1442276A (en) 1977-12-01
AU508625B2 true AU508625B2 (en) 1980-03-27

Family

ID=5947910

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14422/76A Expired AU508625B2 (en) 1975-05-31 1976-05-28 Stable solutions hydrogenated ergopeptide alkaloids

Country Status (26)

Country Link
JP (1) JPS585167B2 (de)
AT (1) AT355725B (de)
AU (1) AU508625B2 (de)
BE (1) BE842348A (de)
CA (1) CA1069438A (de)
CS (1) CS205023B2 (de)
DD (1) DD125597A5 (de)
DK (1) DK154606C (de)
ES (1) ES448372A1 (de)
FI (1) FI761461A (de)
FR (1) FR2313059A1 (de)
GB (1) GB1539083A (de)
GR (1) GR60264B (de)
HK (1) HK15383A (de)
HU (1) HU171514B (de)
IE (1) IE42999B1 (de)
IL (1) IL49668A (de)
MY (1) MY8300013A (de)
NL (1) NL172616C (de)
NO (1) NO145262C (de)
NZ (1) NZ180984A (de)
PT (1) PT65151B (de)
SE (1) SE426782B (de)
SU (2) SU952106A3 (de)
YU (1) YU133076A (de)
ZA (1) ZA763138B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935515A1 (de) * 1979-09-03 1981-03-19 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Arzneipraeparat
FR2483235A1 (fr) * 1980-05-28 1981-12-04 Fabre Sa Pierre Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees
DE3227122A1 (de) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Stabile loesungen von mutterkornalkaloiden
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
IT1200609B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutice per il trattamento delle turbe cerebrovascolari e del cervello anziano
DE102007014947B4 (de) 2007-03-23 2010-05-27 Axxonis Pharma Ag Stabilisierte wässrige Lösungen von Ergolinverbindungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD43402A (de) *
US2033921A (en) * 1931-08-28 1936-03-17 Squibb & Sons Inc Solution of ergot alkaloids
US1969382A (en) * 1932-05-21 1934-08-07 Squibb & Sons Inc Preparation of a stable hydro-alcoholic extract of ergot

Also Published As

Publication number Publication date
PT65151B (fr) 1978-02-06
NO145262C (no) 1982-02-17
AU1442276A (en) 1977-12-01
CA1069438A (en) 1980-01-08
SU677664A3 (ru) 1979-07-30
ZA763138B (en) 1978-01-25
SE426782B (sv) 1983-02-14
IL49668A0 (en) 1976-09-30
IE42999L (en) 1976-11-30
NZ180984A (en) 1978-06-20
JPS51144720A (en) 1976-12-13
FI761461A (de) 1976-12-01
FR2313059A1 (fr) 1976-12-31
ATA390476A (de) 1979-08-15
IE42999B1 (en) 1980-12-03
JPS585167B2 (ja) 1983-01-29
GB1539083A (en) 1979-01-24
ES448372A1 (es) 1978-03-01
CS205023B2 (en) 1981-04-30
DK154606C (da) 1989-05-01
NL172616C (nl) 1983-10-03
AT355725B (de) 1980-03-25
PT65151A (fr) 1976-06-01
NL7605745A (nl) 1976-12-02
GR60264B (en) 1978-04-20
IL49668A (en) 1979-10-31
DK228676A (da) 1976-12-01
SU952106A3 (ru) 1982-08-15
DD125597A5 (de) 1977-05-04
HU171514B (hu) 1978-01-28
DK154606B (da) 1988-12-05
FR2313059B1 (de) 1978-12-15
NO145262B (no) 1981-11-09
MY8300013A (en) 1983-12-31
NO761760L (de) 1976-12-01
YU133076A (en) 1984-08-31
SE7605841L (sv) 1976-12-01
BE842348A (fr) 1976-11-29
HK15383A (en) 1983-05-20
NL172616B (nl) 1983-05-02

Similar Documents

Publication Publication Date Title
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU508160B2 (en) Cyclization
AU1670276A (en) Tetrahydro-isoquinolines
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU1829576A (en) Hydropyrimidines
AU1667476A (en) Chroman-4-ones
AU1128976A (en) Magneto-alternator
AU1637076A (en) Banjo-shaped axle-casing
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
AU1710076A (en) Dihydrooxadiazinones
AU501137B2 (en) Benzyl alcohol derivatives
AU1722876A (en) Antimacassar
AU1565576A (en) L- pyroglutamyl-l-prolinamide
AU508625B2 (en) Stable solutions hydrogenated ergopeptide alkaloids
AU1719976A (en) Silacyclo pentenyl-bis-epsilon-caprolactam
AU1520376A (en) Benzocycloheptathiophens
AU1408076A (en) Lysolipin Antibioties
AU1191776A (en) Fluoro-prostaglandins
AU1393076A (en) Dihydromocimycin
AU1804876A (en) 4-hydroxymethyl-2-pyrrolidinones